Table 1 Univariate statistics and multivariate logistic regression analysis of patients’ characteristics and laboratory findings on admission

Age (years)

57.31 ± 14.27

52.20 ± 15.84

0.173

Sex: Male (n %)

12(46.15%)

29(55.77%)

0.423

Rural area (n %)

21(80.77%)

44(84.61%)

0.667

 Respiratory diseases (n %)

3(11.53%)

7(13.46%)

0.811

 Chronic kidney diseases (n %)

2(7.69%)

4(7.69%)

1.000

 Hepatitis B (n %)

3(11.53%)

3(5.77%)

0.367

 Hypertension (n %)

4(15.38%)

2(3.85%)

0.071

(0.026,1.109)

 Autoimmune disease (n %)

3(11.53%)

4(7.69%)

0.575

 Hematology and oncology (n %)

0

1(1.92%)

0.477

 The duration before confirmed diagnosis (days)

27.00 ± 23.13

26.30 ± 18.93

0.501

 Duration of DM II course (years)

4.20 ± 3.34

–

–

 Fever (n %)

21(80.77%)

39(75.00%)

0.569

 Headache (n %)

25(96.15%)

50(96.15%)

1.000

 Nausea/Vomiting (n %)

16(61.54%)

25(48.07%)

0.262

 Vision disorders (n %)

8(28.54%)

6(11.54%)

0.038*

(0.056,0.705)

 Auditory symptoms (n %)

2(7.69%)

4(7.69%)

1.000

 Seizure (n %)

3(11.54%)

3(5.77%)

0.367

 Conscious disturbance (n %)

8(30.77%)

9(17.31%)

0.175

 Opening pressure (mmH₂O)

271.54 ± 100.78

234.23 ± 105.98

0.125

 CSF protein (mg/l)

1027.62 ± 594.16

705.72 ± 373.88

0.031*

(1.000,1.002)

2.08 ± 1.01

2.30 ± 1.41

0.250

 Positive India ink stain (n %)

19(73.08%)

40(76.92%)

0.709

 Positive cryptococcal antigen (n %)

25(96.15%)

50(96.13%)

1.000

 Positive culture result (n %)

17(65.38%)

32(61.54%)

0.740

 Meningeal enhancement (n %)

10(38.46%)

22(42.30%)

0.745

 Hydrocephalus (n %)

2(7.69%)

4(7.69%)

1.000

 Cerebral infarction (n %)

4(15.38%)

6(11.54%)

0.632

 Abscess (n %)

2(7.69%)

2(3.84%)

0.468

 Normale^a (n %)

8(30.77%)

18(34.62%)

0.734